Literature DB >> 9390567

Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.

B E Sha1, R D D'Amico, A L Landay, G T Spear, L S Massad, R J Rydman, N A Warner, J Padnick, L Ackatz, L A Charles, C A Benson.   

Abstract

We analyzed 21 cervicovaginal lavage (CVL) specimens from 19 women participating in the Women's Interagency HIV Study to characterize levels of antibody, cytokine, and complement and to determine associations between these levels and stage of the menstrual cycle, HIV status, and the presence of concurrent genital infection and genital dysplasia. Sixteen samples were collected from HIV-infected women and five from high-risk HIV-seronegative women. CVL fluid was assayed for levels of IgG, secretory IgA (s-IgA), interleukin 2 (IL-2), IL-10, IL-6, tumor necrosis factor alpha (TNF-alpha), IL-1beta, interferon gamma (IFN-gamma), C3, C1q, and C4. Women with HIV were more likely to have cervicovaginal dysplasia (9/16 vs. 0/5; p = 0.027) but were not more likely to have concurrent vaginal infection (10/16 vs. 2/5; p = 0.38). Antibody, cytokine, and complement were detectable in all samples, although not all samples had measurable IL-10, C3, or C4. HIV-infected women demonstrated a trend toward higher levels of IFN-gamma than did uninfected women (p = 0.098); no differences were noted in other parameters. HIV-infected women with vaginal infections had significantly higher CVL levels of IgG (p = 0.023) and IFN-gamma (p = 0.02) than did HIV-infected women without genital infections. HIV-infected women with cervicovaginal dysplasia were found to have higher levels of IL-1beta (p = 0.045) and IFN-gamma (p = 0.039) than those without. Analysis of the HIV-infected cohort by CD4 cell count revealed higher levels of IgG and IFN-gamma in CVL from women with lower CD4 cell counts, although these differences were not statistically significant. Higher levels of proinflammatory cytokines in CVL fluid of women with genital infection or cervicovaginal dysplasia may affect local HIV replication and may influence the risk of acquisition or transmission of HIV for women with these underlying conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390567     DOI: 10.1097/00042560-199711010-00004

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  7 in total

Review 1.  Guiding the vaginal microbicide trials with biomarkers of inflammation.

Authors:  Raina N Fichorova
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10       Impact factor: 3.731

2.  Genital tract leukocytes and shedding of genital HIV type 1 RNA.

Authors:  Brenna L Anderson; Chia-Ching Wang; Allison K Delong; Tao Liu; Erna Milu Kojic; Jaclynn Kurpewski; Jessica Ingersoll; Kenneth Mayer; Angela M Caliendo; Susan Cu-Uvin
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

3.  A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.

Authors:  Athena P Kourtis; Lisa Haddad; Jennifer Tang; Lameck Chinula; Stacey Hurst; Jeffrey Wiener; Sascha Ellington; Julie A E Nelson; Amanda Corbett; Kristina De Paris; Caroline C King; Mina Hosseinipour; Irving F Hoffman; Denise J Jamieson
Journal:  Contemp Clin Trials       Date:  2016-11-09       Impact factor: 2.226

4.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

5.  Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method.

Authors:  James E Cummins; Julie M Villanueva; Tammy Evans-Strickfaden; Shekou M Sesay; Sheila R Abner; Timothy J Bush; Timothy A Green; Jeffrey L Lennox; Thomas Wright; Thomas M Folks; Clyde E Hart; Charlene S Dezzutti
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

6.  Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study.

Authors:  Kian Behbakht; Jennifer Friedman; Ira Heimler; Alla Aroutcheva; Jose Simoes; Sebastian Faro
Journal:  Infect Dis Obstet Gynecol       Date:  2002

7.  Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women.

Authors:  Phyllis Losikoff; Raina Fichorova; Brad Snyder; Irma Rodriguez; Susan Cu-Uvin; Joseph Harwell; Kenneth H Mayer
Journal:  Infect Dis Obstet Gynecol       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.